| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
1 |
| Metabolic Syndrome |
0 |
1 |
| Liver |
0 |
0.89 |
| Fatty Liver |
0 |
0.87 |
| HIV Infection |
0 |
0.79 |
| Liver Disease |
0 |
0.7 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.33 |
| Pregnancy |
0 |
0.3 |
| Weight Management |
0 |
0.25 |
| Outpatient Clinic |
0 |
0.2 |
| Health Care Reform |
0 |
0.16 |
| Obesity |
0 |
0.15 |
| Weight Gain |
0 |
0.15 |
| Weight Loss |
0 |
0.15 |
| Scan |
0 |
0.1 |
| Steatosis |
0 |
0.1 |
| Transplantation |
0 |
0.1 |
| AIDS |
0 |
0.05 |
| Biopsy |
0 |
0.05 |
| Body Mass Index |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Fellowship |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Nonalcoholic Steatohepatitis |
0 |
0.05 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.05 |
| Pandemic |
0 |
0.05 |
| Ultrasonography |
0 |
0.05 |
| Viral Load |
0 |
0.05 |
| Cardiovascular Risk Management |
0 |
0.04 |
| COVID-19 |
0 |
0.04 |